These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 30250990)

  • 1. Current and Emerging Preclinical Approaches for Imaging-Based Characterization of Atherosclerosis.
    Vigne J; Thackeray J; Essers J; Makowski M; Varasteh Z; Curaj A; Karlas A; Canet-Soulas E; Mulder W; Kiessling F; Schäfers M; Botnar R; Wildgruber M; Hyafil F;
    Mol Imaging Biol; 2018 Dec; 20(6):869-887. PubMed ID: 30250990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MRI, the technology for imaging of thrombi and inflammation.
    von Zur Muhlen C; Bode C
    Hamostaseologie; 2015; 35(3):252-62. PubMed ID: 25634650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular Imaging of Atherothrombotic Diseases: Seeing Is Believing.
    Wang X; Peter K
    Arterioscler Thromb Vasc Biol; 2017 Jun; 37(6):1029-1040. PubMed ID: 28450298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dynamic contrast enhanced (DCE) magnetic resonance imaging (MRI) of atherosclerotic plaque angiogenesis.
    Calcagno C; Mani V; Ramachandran S; Fayad ZA
    Angiogenesis; 2010 Jun; 13(2):87-99. PubMed ID: 20526859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular Imaging of Vulnerable Atherosclerotic Plaques in Animal Models.
    Gargiulo S; Gramanzini M; Mancini M
    Int J Mol Sci; 2016 Sep; 17(9):. PubMed ID: 27618031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PET and SPECT imaging of apoptosis in vulnerable atherosclerotic plaques with radiolabeled Annexin A5.
    Laufer EM; Winkens HM; Corsten MF; Reutelingsperger CP; Narula J; Hofstra L
    Q J Nucl Med Mol Imaging; 2009 Feb; 53(1):26-34. PubMed ID: 19182725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular imaging of matrix metalloproteinases in atherosclerotic plaques.
    Lenglet S; Thomas A; Chaurand P; Galan K; Mach F; Montecucco F
    Thromb Haemost; 2012 Mar; 107(3):409-16. PubMed ID: 22274652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular imaging of inflammation in atherosclerosis.
    Wildgruber M; Swirski FK; Zernecke A
    Theranostics; 2013 Nov; 3(11):865-84. PubMed ID: 24312156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Animal models of atherosclerosis and magnetic resonance imaging for monitoring plaque progression.
    Millon A; Canet-Soulas E; Boussel L; Fayad Z; Douek P
    Vascular; 2014 Jun; 22(3):221-37. PubMed ID: 24907292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tandem Stenosis to Induce Atherosclerotic Plaque Instability in the Mouse.
    Chen YC; Rivera J; Peter K
    Methods Mol Biol; 2015; 1339():333-8. PubMed ID: 26445800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Imaging of atherosclerosis].
    Casella G; Prati F; Klauss V; Coutsoumbas G; Di Pasquale G
    G Ital Cardiol (Rome); 2009 Dec; 10(11-12 Suppl 3):4S-12S. PubMed ID: 21298855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Does Lp-PLA2 determination help predict atherosclerosis and cardiocerebrovascular disease?].
    Sertić J; Skorić B; Lovrić J; Bozina T; Reiner Z
    Acta Med Croatica; 2010 Oct; 64(4):237-45. PubMed ID: 21688606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nuclear Molecular Imaging for Vulnerable Atherosclerotic Plaques.
    Lee SJ; Paeng JC
    Korean J Radiol; 2015; 16(5):955-66. PubMed ID: 26357491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting P-selectin by gallium-68-labeled fucoidan positron emission tomography for noninvasive characterization of vulnerable plaques: correlation with in vivo 17.6T MRI.
    Li X; Bauer W; Israel I; Kreissl MC; Weirather J; Richter D; Bauer E; Herold V; Jakob P; Buck A; Frantz S; Samnick S
    Arterioscler Thromb Vasc Biol; 2014 Aug; 34(8):1661-7. PubMed ID: 24903095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ex-vivo imaging and plaque type classification of intracranial atherosclerotic plaque using high resolution MRI.
    Jiang Y; Zhu C; Peng W; Degnan AJ; Chen L; Wang X; Liu Q; Wang Y; Xiang Z; Teng Z; Saloner D; Lu J
    Atherosclerosis; 2016 Jun; 249():10-6. PubMed ID: 27062404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contrast-enhanced ultrasound imaging detects intraplaque neovascularization in an experimental model of atherosclerosis.
    Giannarelli C; Ibanez B; Cimmino G; Garcia Ruiz JM; Faita F; Bianchini E; Zafar MU; Fuster V; Garcia MJ; Badimon JJ
    JACC Cardiovasc Imaging; 2010 Dec; 3(12):1256-64. PubMed ID: 21163454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carotid Plaque Lipid Content and Fibrous Cap Status Predict Systemic CV Outcomes: The MRI Substudy in AIM-HIGH.
    Sun J; Zhao XQ; Balu N; Neradilek MB; Isquith DA; Yamada K; Cantón G; Crouse JR; Anderson TJ; Huston J; O'Brien K; Hippe DS; Polissar NL; Yuan C; Hatsukami TS
    JACC Cardiovasc Imaging; 2017 Mar; 10(3):241-249. PubMed ID: 28279371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Statistical Permutation-based Artery Mapping (SPAM): a novel approach to evaluate imaging signals in the vessel wall.
    Seifert R; Scherzinger A; Kiefer F; Hermann S; Jiang X; Schäfers MA
    BMC Med Imaging; 2017 May; 17(1):36. PubMed ID: 28549448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombosis formation on atherosclerotic lesions and plaque rupture.
    Badimon L; Vilahur G
    J Intern Med; 2014 Dec; 276(6):618-32. PubMed ID: 25156650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Matrix-metalloproteinases as imaging targets for inflammatory activity in atherosclerotic plaques.
    Schäfers M; Schober O; Hermann S
    J Nucl Med; 2010 May; 51(5):663-6. PubMed ID: 20439506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.